When to operate pancreatic intraductal papillary mucinous neoplasm: Literature review

Read full text Summarise with VIRAT
Authors: Thamer H. Alghamdi
Cited by: 0
References: 66

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Management of intraductal papillary mucinous neoplasms (IPMNs) is debated due to differing guidelines. The aim is to identify the timing of surgery and follow-up, as well as how to prioritize the imaging technique. We reviewed all IPMNs guidelines. Sendai guidelines recommended surgical resection for all main duct IPMNs and mixed-type IPMNs if the patient is healthy resulting in increased morbidity and mortality. International Association of Pancreatology Fukuoka guidelines introduced “worrisome feature” and “high-risk stigmata (HRS)”. International Consensus Guidelines recommended that surgery for all cases of main duct IPMNs with a main pancreatic diameter of more than 10 mm or associated with HRS. European Experts Consensus statement guidelines revealed absolute and relative indications for surgery of cases with high-risk IPMNs, considering the size of the cyst with a cut-off point of 4 cm. Fukuoka’s definitions of HRS and worrisome feature and planned the surgery for all mucinous type. American Gastroenterological Association guidelines restricted surgery for non-symptomatic patients. European guidelines recommend surgery in presence of jaundice, an enhanced mural nodule ≥ 5 mm, or have a solid component, positive malignancy and others. Although most of these guidelines showed agreement on the timing of surgery types of IPMNs, there are still debates about the timing of surveillance/follow-up and selection/prioritization of the imaging technique, despite new trials have emerged.

Fields of Study & Subjects

Pancreatic and Hepatic Oncology Research Neuroendocrine Tumor Research Advances Pancreatitis Pathology and Treatment

Publication details

Journal / source
World Journal of Clinical Oncology
Volume
17
Issue
3
Publication date
23 March 2026
Language
EN